EPISODE · Apr 25, 2025 · 31 MIN
Ep. 291 - Grand Rounds - U.S. Preview
from BioCentury This Week · host BioCentury
The academia-industry interface is more important than ever for sustaining biomedical innovation’s forward momentum, even as the Trump administration injects turbulence into academic funding for universities. On a special edition of the BioCentury This Week podcast, BioCentury’s Simone Fishburn and Karen Tkach Tuzman preview Grand Rounds, BioCentury’s second annual R&D conference, along with special guests.Spots are filling up for the Grand Rounds U.S. Presenting Company Class of 2025. Find out how to apply here.View full story: https://www.biocentury.com/article/655696#biotech #biopharma #pharma #lifescience #academia #chicago #asco00:00 - Introduction01:42 - Key Themes and Featured Sessions07:37 - Chicago's Role in Biotech Innovation15:06 - McKinsey's Insights25:18 - Upcoming Events and Networking OpportunitiesTo submit a question to BioCentury’s editors, email the BioCentury This Week team at [email protected] us by sending a text
Embed this episode
What this episode covers
The academia-industry interface is more important than ever for sustaining biomedical innovation’s forward momentum, even as the Trump administration injects turbulence into academic funding for universities. On a special edition of the BioCentury This Week podcast, BioCentury’s Simone Fishburn and Karen Tkach Tuzman preview Grand Rounds, BioCentury’s second annual R&D conference, along with special guests. Spots are filling up for the Grand Rounds U.S. Presenting Company Class of 2025. F...
NOW PLAYING
Ep. 291 - Grand Rounds - U.S. Preview
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.